← Back to EMF Signal
Bioengineering
Therapeutic
Review: Pulsed electromagnetic fields for narrowed leg arteries and diabetic circulation run at low frequency and weak field strength, and the evidence from 32 studies is mixed
A group at Moscow's Petrovsky National Research Center of Surgery sifted 2979 search hits in Scopus, PubMed and Web of Science, with AI help and investigator checks, and mapped the 32 reports that paired a pulsed electromagnetic field with a measured blood-flow outcome in an arm or a leg. The doses that keep coming back are weak and low-frequency, around 10 to 30 Hz and often near 15 Hz at about 2 millitesla, in small studies of narrowed leg arteries and diabetes. Results ran positive, mixed and null, and the review declines to infer efficacy: small samples, uncommon sham controls, incomplete dosimetry. The second half proposes a device that would tune the field in real time from limb bioimpedance, which the authors say needs testing.
🔬 This research is covered in EMF Signal's section on therapeutic EMF applications. It investigates controlled use of electromagnetic fields as potential treatment, not environmental exposure.
Exposure note: PAD is peripheral arterial disease, narrowed arteries in the legs. The charted exposures run from microtesla fields to a 0.8 tesla technical setup, and include one study with a burst-radiofrequency regimen on a 27.12 MHz carrier dosed by forward power rather than by field strength.
Quotes
"Clinical studies reported heterogeneous peripheral-circulation or vascular-proxy findings, with positive, mixed, and null results across different designs and endpoints; they do not establish clinical efficacy."
— Hammoud et al., Bioengineering
"Clinical samples were generally small, sham control was uncommon, co-interventions were frequent, and six reports were charted from abstracts only."
— Hammoud et al., Bioengineering
"No study identified by the present strategy used validated limb bioimpedance pulse-wave features to adapt PEMF parameters continuously for a peripheral-circulation target."
— Hammoud et al., Bioengineering
Exposure
"Low-frequency, low-mT regimens around 10–30 Hz recur, particularly near 15 Hz in small PAD and diabetes studies, but the literature does not establish a universal optimum for frequency, field strength, waveform, session duration, or course length."
— Hammoud et al., Bioengineering
"Radiofrequency and low-frequency exposures cannot be compared by magnetic flux density alone because the induced electric field and duty cycle differ by orders of magnitude."
— Hammoud et al., Bioengineering
Location
📍 Russia
EMF Signal - tracking the EMF conversation worldwide
📄 Underlying Research
Pulsed Electromagnetic Fields and Bioimpedance Monitoring of Peripheral Circulation: A Scoping Review and Proposed Adaptive Control Framework
Hammoud A, Briko A, Kapravchuk V, Malakhov A, Shchukin S
(2026)
Bioengineering
Journal Level 1ⓘ
